Clinical Trials Logo

Adherence, Patient clinical trials

View clinical trials related to Adherence, Patient.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06078319 Completed - Adherence, Patient Clinical Trials

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

RAMP
Start date: January 18, 2021
Phase:
Study type: Observational

The prospective multicenter observational cohort study will be offered consecutively to any patient with primary or secondary myelofibrosis or with Polycythemia Vera who has initiated therapy with ruxolitinib, prescribed as part of the normal course of care and completely independent of study participation. The main purpose is to assess adherence to ruxolitinib using the ARMS questionnaire. Each individual patient will be administered the questionnaire at the first convenient opportunity, regardless of when ruxolitinib is started, and again after 4, 8, 12, 24, and 48 weeks, in conjunction with drug procurement.

NCT ID: NCT06068699 Completed - Adherence, Patient Clinical Trials

Postcards to Improve Remote Monitoring Adherence Among Veterans

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

We tested the effect of informational postcards on improving remote monitoring adherence among Veterans with pacemakers and implantable cardioverter-defibrillators in a stepped-wedge randomized controlled trial.

NCT ID: NCT05921565 Completed - Adherence, Patient Clinical Trials

M-POWER Feasibility Study

M-POWER
Start date: March 11, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to test a new weight loss intervention designed for cancer survivors who have heart disease or cardiometabolic conditions. The investigators want to determine whether this study is feasible and acceptable to participants. The investigators also want to learn more about how cancer survivors take their medications.

NCT ID: NCT05556967 Completed - Adherence, Patient Clinical Trials

Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

Start date: August 9, 2023
Phase: N/A
Study type: Interventional

This is a pilot study for identifying plasma and/or urine-derived adherence/surrogate biomarker candidates for verifying Immulina™ ingestion by human volunteers (collected before and after consumption of Immulina™, a natural dietary supplement).

NCT ID: NCT05041439 Completed - Adherence, Patient Clinical Trials

Adherence to Care for Children With Congenital Zika Virus Infection in Puerto Rico

Start date: July 6, 2021
Phase: N/A
Study type: Interventional

Given the magnitude of the epidemic in Puerto Rico, congenital Zika virus infection may have devastating complications to a significant population of children, also affecting families and society at large. This proposal takes a critical first step to ensuring that children with exposure to congenital Zika virus infection receive the follow-up care they need for optimal clinical outcomes. We anticipate that lessons learned from this study may also positively impact models for adherence to early intervention services in Puerto Rico.

NCT ID: NCT05038215 Completed - Clinical trials for Obstructive Sleep Apnea

Increasing Adherence to Oral Appliance Therapy for Obstructive Sleep Apnea

Start date: December 5, 2017
Phase: N/A
Study type: Interventional

Obstructive sleep apnea is a chronic condition that has serious health consequences including increased risk of hypertension, type-2 diabetes, heart disease, stroke and reduced life expectancy. This study proposes to use behavioral reinforcement and support to increase adherence to oral appliance therapy for obstructive sleep apnea. The control group in the study will receive routine care. In addition, their oral appliance wear time will be monitored using a sensor built into the appliance. Routine care includes an initial 1-hr consult, then delivery of the oral appliance (with sensor) and follow-up appointments at 1 week, 1 month, 3 months, 6 months, and 1 year. The second, experimental group will receive adherence promotion techniques in addition to routine care. These adherence promotion techniques can be categorized into 6 methods. 1- spouse/partner included in a patient counseling session. 2- Educational brochure delivery at follow up appointments. 3- Electronic reminder/communication system established by patient and provider. 4-Follow up communication between primary care physician and orthodontist. 5-Celebratory certificate for good adherence with the oral appliance evaluated at 3 month, and 6 month visits. 6-Gift card delivery, $25, when patient schedules a follow up with sleep physician. Patients will be followed for within the research protocol for 6 months. There are no additional risks involved with the research and the anticipated benefit is to develop methods to increase adherence to treatment for obstructive sleep apnea. This will benefit many patients with obstructive sleep apnea who use oral appliances to control the condition.

NCT ID: NCT04817176 Completed - Clinical trials for Mild Cognitive Impairment

MI-CBT Adherence Program for Lifestyle Interventions in Older Adults

MI-CBT KNAP
Start date: September 24, 2021
Phase: Early Phase 1
Study type: Interventional

Objective 1: Assess feasibility and acceptability of all protocol components of a pilot trial testing a 6-week telehealth Mediterranean ketogenic nutrition adherence (KNA) program using motivational interviewing and cognitive behavioral strategies (MI-CBT) compared to a KN information only group for older adults with mild cognitive impairment (MCI) to prepare for a full-scale trial. Specifically, the investigators will examine the feasibility of the recruitment, retention, assessment, and intervention delivery methods. The investigators hypothesize that: 1. The study protocol will result in high patient retention (90%) and patient attendance of intervention sessions (80%), and 2. A centralized MI-CBT telehealth delivery approach will be associated with high intervention acceptability ratings from patients. Objective 2: Assess signal of initial effect of the KNA program on important clinical outcomes and adherence relative to a KN information-only condition. The investigators hypothesize that patients in the KNA condition, relative to the KN-only condition, will show: 1. higher rates of clinically significant improvements on the RBANS total scale scores, improvements in daily functioning (FSQ), and decreases in patient CAIDE risk score( (Cardiovascular Risk Factors, Aging, and Incidence of Dementia), and 2. improved adherence to KN, as evidenced by higher levels of measurable urine ketones in the KNA condition compared to the KN-only condition.

NCT ID: NCT04413708 Completed - HIV/AIDS Clinical Trials

mHealth Technologies to Enhance PrEP Adherence Among Thai MSM

P3-T
Start date: June 12, 2020
Phase: N/A
Study type: Interventional

This study aims to: 1) adapt the theory-based P3 (Prepared, Protected, emPowered) app designed to improve pre-exposure prophylaxis (PrEP) adherence, retention in PrEP clinical care, and PrEP persistence among young men who have sex with men (YMSM) in the United States for YMSM in Thailand, and 2) conduct a pilot randomized controlled trial (RCT) to assess the feasibility, acceptability, and potential impact of the adapted P3-Thailand (P3-T) app.

NCT ID: NCT04404556 Completed - Type 1 Diabetes Clinical Trials

Diabetes Journey: An Adolescent Adherence Barriers Intervention

Start date: August 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility, acceptability, and preliminary efficacy of a web-based intervention addressing adherence barriers in adolescents with T1D.

NCT ID: NCT04256304 Completed - Type 2 Diabetes Clinical Trials

The Effect of The Personalized Patient Engagement Plan on Diabetes Management

Start date: December 28, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of Personalized Patient Engagement Plan on diabetes management in patients with at least six months of Type-2 Diabetes. The research is planned to be carried out as an experimental study with pretest-posttest control groups. Half of the participants will receive the Personalized Patient Engagement Plan; between two 2 face-to-face sessions including motivational interviews, one telephone coaching call and patient-driven home-based exercises will be conducted. Another half will receive usual care.